Kengo Kidokoro

Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging

Kengo Kidokoro, David Z.I. Cherney, Andrea Božović et al. · Circulation · 2019 · 276 citations · Full text

Medicine, Nephrology, Pharmacology +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status

Yuko Nishi, Minoru Satoh, Hajime Nagasu et al. · Kidney International · 2013 · 81 citations · Full text

Life Sciences, Endocrinology, Nephrology +16

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris et al. · Nephrology Dialysis Transplantation · 2024 · 77 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16